{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:38:20Z","timestamp":1753601900303},"reference-count":37,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1586\/eri.09.37","type":"journal-article","created":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T05:55:41Z","timestamp":1243922141000},"page":"507-514","source":"Crossref","is-referenced-by-count":5,"title":["Doripenem: position in clinical practice"],"prefix":"10.1586","volume":"7","author":[{"given":"Harakh V","family":"Dedhia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","unstructured":"Doripenem. Package insert, Johnson & Johnson, Raritan, NJ, USA."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit. Care Med."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh298"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/46.3.471","volume":"46","author":"Mikamo","year":"2000","journal-title":"J. Antimcrob. Chemother."},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.clinthera.2008.04.001","volume":"30","author":"Merchant","year":"2008","journal-title":"Clin. Ther."},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1097\/01.CCM.0000181731.53912.D9","volume":"33","author":"Safdar","year":"2005","journal-title":"Crit.. Care Med."},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1378\/chest.122.6.2115","volume":"122","author":"Rello","year":"2002","journal-title":"Chest"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.9.1320"},{"key":"CIT0009","unstructured":"Evangelista AT, Yee C, Pillar CMet al.Surveillance profiling of doripenem activity againstPseudomonas aeruginosaisolated from inpatients and ICU patients: results of the TRUST surveillance initiative. Presented at:The 45th Annual Meeting of the Infectious Diseases Society (IDSA). CA, USA, 4\u20137 October 2007."},{"key":"CIT0010","unstructured":"Jones ME, Draghi DC, Brown NPet al.Baseline surveillance profile of doripenem (DOR) against key Gram-negative pathogens encountered in the United States. Presented at:The 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). CA, USA, 27\u201330 September 2006."},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ja.2006.31","volume":"59","author":"Sakyo","year":"2006","journal-title":"J. Antibiot."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3086-3092.2004"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.01529-07","volume":"52","author":"Davies","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0014","author":"Kim","year":"2008","journal-title":"Am. Soc. Microbiol."},{"key":"CIT0015","unstructured":"Aransas-Torres M, Pillar C, Shah D, Sahm D. Stratified analysis of doripenem activity against enterobacteriacae andPsuedomonas aeruginosaaccording to patient location: inpatients and ICU patients. Presented at:47th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, IL, USA, 17\u201320 September (2007)."},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00381-08","volume":"52","author":"Pillar","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/AAC.49.9.3944-3947.2005","volume":"49","author":"Bhavnani","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1358\/dot.2006.42.6.985634","volume":"42","author":"Anderson","year":"2006","journal-title":"Drugs Today"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diagmicrobio.2004.12.008","volume":"52","author":"Jones","year":"2005","journal-title":"Diagn. Microb. Infect. Dis."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2327-2332.2002"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.00464-08","volume":"52","author":"Tanimoto","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3086-3092.2004"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/AAC.42.1.94","volume":"42","author":"Tsuji","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.clinthera.2008.11.013","volume":"30","author":"Psathas","year":"2008","journal-title":"Clin. Ther."},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2146\/ajhp070574","volume":"65","author":"Brammer","year":"2008","journal-title":"Am J. Health System Pharm."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki134"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6818","volume":"12","author":"Nicolau","year":"2008","journal-title":"Crit.Care"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6819","volume":"12","author":"Owens","year":"2008","journal-title":"Crit. Care"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6994","volume":"12","author":"Slama","year":"2008","journal-title":"Crit. Care"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2006.02.004"},{"key":"CIT0031","unstructured":"Lucasti C, Jasovich A, Umeh Oet al.Treatment of complicated intra-abdominal infections: doripenem versus meropenem. Presented at:The 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, CA, USA, 27\u201330 September 2006."},{"key":"CIT0032","unstructured":"Solomkin JS, Umeh O, Jiang Jet al.Doripenem versus meropenem with an option for oral step-down therapy in the treatment of complicated intra-abdominal infections. Presented at:The 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). CA, USA, 27\u201330 September 2006."},{"key":"CIT0033","unstructured":"Malafia O, Umeh O, Jiang J. Doripenem versus meropenem for the treatment of complicated intra-abdominal infections. Presented at:The 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). CA, USA, 27\u201330 September 2006."},{"key":"CIT0034","unstructured":"Kaniga K, Redman R, Llorens L, Friedland I. Prevalence of ESBLs and flouroquinolone resistant isolates form Phase 3 trials of complicated urinary tract infections including pyelonephritis. Presented at:The 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, IL, USA, 17\u201320 September 2007."},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"Naber K, Redman R, Kotey P, Llorens L, Kaniga K. Intravenous therapy with doripenem versus levofloxacin with an option to oral step-down therapy in the treatment of complicated urinary tract infection and pyelonephritis. Presented at:The European Society of Clinical Microbiology and Infectious Diseases. Munich, Germany, 31 March \u2013 3 April 2007.","DOI":"10.1016\/S0924-8579(07)70674-X"},{"key":"CIT0036","unstructured":"Goldstein E, Citron D, Merriam CV, Warren Y, Tyrrell K, Fernandez H.In vitroactivity of doripenem against aerobic and anerobic bacteria isolated from infected diabetic foot wounds. Presented at:The 47th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, IL, USA, 17\u201320 September 2007."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.01153-07","volume":"52","author":"MacGowan","year":"2008","journal-title":"Antimicrob. Agent Chemother."}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/eri.09.37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T10:57:57Z","timestamp":1558349877000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/eri.09.37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1586\/eri.09.37"],"URL":"https:\/\/doi.org\/10.1586\/eri.09.37","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}